MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
Author(s) -
Götz Thomalla,
Claus Z. Simonsen,
Florent Boutitie,
Grethe Andersen,
Yves Berthezène,
Bastian Cheng,
Bharath Kumar Cheripelli,
TaeHee Cho,
Franz Fazekas,
Jens Fiehler,
Ian Ford,
Ivana Galinović,
Susanne Gellißen,
Amir Golsari,
Johannes Gregori,
Matthias Günther,
Jorge Guibernau,
Karl Georg Häusler,
Michael G. Hennerici,
André Kemmling,
Jacob Marstrand,
Boris Modrau,
Lars Neeb,
Natàlia Pérez de la Ossa,
Josep Puig,
Peter Ringleb,
Pascal Roy,
Enno Scheel,
Wouter J. Schonewille,
Joaquı́n Serena,
Stefan Sunaert,
Kersten Villringer,
Anke Wouters,
Vincent Thijs,
Martin Ebinger,
Matthias Endres,
Jochen B. Fiebach,
Robin Lemmens,
Keith W. Muir,
Norbert Nighoghossian,
Salvador Pedraza,
Christian Gerloff
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1804355
Subject(s) - thrombolysis , medicine , magnetic resonance imaging , stroke (engine) , cardiology , cerebral infarction , infarction , acute stroke , radiology , tissue plasminogen activator , myocardial infarction , ischemia , engineering , mechanical engineering
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be ascertained that the time since the onset of symptoms was less than 4.5 hours. We sought to determine whether patients with stroke with an unknown time of onset and features suggesting recent cerebral infarction on magnetic resonance imaging (MRI) would benefit from thrombolysis with the use of intravenous alteplase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom